The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Pellagra Treatment Market 2026
US$ 2,999.00
The Pellagra Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.05 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
207 pages
Bloom Syndrome Treatment Market 2026
US$ 2,999.00
The Bloom Syndrome Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regi...
November 2025
223 pages
Urinary Incontinence Therapeutics Market Size, Share & Trends Analysis Report By Type (Stress Incontinence, Urge Incontinence), By Drug Class, By Gender, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global urinary incontinence therapeutics market size was estimated at USD 4.32 billion in 2024 and is projected to reach USD 6.95 billion by 2033, growing at a CAGR of 5.4% from 2025 to 2033. This...
November 2025
150 pages
U.S. Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report By Product (Viscosupplements, Platelet-Rich Plasma Therapy, Adipose Tissue Therapy, Bone Graft Substitutes), By Application, By Primary User, And Segment Forecasts, 2025 - 2033
US$ 3,950.00
The U.S. osteoarthritis therapeutics market size was estimated at USD 2.15 billion in 2024 and is projected to reach USD 4.50 billion by 2033, growing at a CAGR of 8.61% from 2025 to 2033. Growing ger...
November 2025
190 pages
Non-alcoholic Steatohepatitis Treatment Market 2026
US$ 2,999.00
The Non-alcoholic Steatohepatitis Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.54 from 2026 to 2032. The report delivers in-depth insights into key market dynamics...
November 2025
210 pages
Global Oral Diuretic Drugs Market Growth 2025-2031
US$ 3,660.00
The global Oral Diuretic Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The global pharmaceutical marke...
November 2025
119 pages
Intersectional Neurodiversity Market Forecasts to 2032 – Global Analysis By Neurodivergent Condition (Autism Spectrum Disorder (ASD), Attention Deficit Hyperactivity Disorder (ADHD), Dyslexia and Learning Disabilities, Tourette Syndrome, Sensory Processing Disorder and Other Conditions), Component, Deployment Mode, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Intersectional Neurodiversity Market is accounted for $135.3 million in 2025 and is expected to reach $314.5 million by 2032 growing at a CAGR of 12.8% during...
November 2025
200 pages
Non-Pharmacologic Modulators Market Forecasts to 2032 – Global Analysis By Modality (Cognitive Behavioral Therapy (CBT), Mindfulness-Based Stress Reduction (MBSR), Biofeedback, Neurofeedback, Transcranial Magnetic Stimulation (TMS) and Other Modalities), Mechanism of Action, Delivery Mode, Distribution Channel, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Non-Pharmacologic Modulators Market is accounted for $1.78 billion in 2025 and is expected to reach $2.55 billion by 2032 growing at a CAGR of 5.2% during the...
November 2025
200 pages
Pharma Hub And Patient Access Support Service Market Size, Share & Trends Analysis Report By Service Type (Program Enrollment, Treatment Navigators, Reimbursement Services/Affordability Services, Clinical Educator), By Service Delivery Type, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global pharma hub and patient access support service market size was estimated at USD 3.24 billion in 2024 and is projected to reach USD 7.63 billion by 2033, growing at a CAGR of 10.0% from 2025...
November 2025
100 pages
U.S. Urinary Incontinence Therapeutics Market Size, Share & Trends Analysis Report By Type (Stress Incontinence, Urge Incontinence), By Drug Class, By Gender, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 3,950.00
The U.S. urinary incontinence therapeutics market size was estimated at USD 1.55 billion in 2024 and is projected to reach USD 2.41 billion by 2033, growing at a CAGR of 5.06% from 2025 to 2033. The U...
November 2025
150 pages
Asia Pacific Bacterial Vaginosis Drug Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription Drugs and Over-the-Counter Drugs), Route of Administration (Oral, Topical, and Vaginal), Dosage Form (Creams, Gels, Pills, Solutions/Washes, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Asia Pacific bacterial vaginosis (BV) drug market is projected to experience significant growth, with an expected market size of approximately US$ 691.1 million by 2031, up from US$ 380.6 million...
November 2025
167 pages
Asia Pacific Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Asia Pacific Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 508.7 billion by 2031, up from US$ 304.0 billion in 2024. This growth represents a compound ann...
November 2025
230 pages
Europe Bacterial Vaginosis Drug Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription Drugs and Over-the-Counter Drugs), Route of Administration (Oral, Topical, and Vaginal), Dosage Form (Creams, Gels, Pills, Solutions/Washes, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Europe Bacterial Vaginosis (BV) Drug Market is projected to grow significantly, reaching an estimated US$ 1,060.6 million by 2031, up from US$ 607.2 million in 2024. This growth represents a compo...
November 2025
165 pages
Europe Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route Of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Europe Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 537.6 billion by 2031, up from US$ 335.0 billion in 2024, reflecting a compound annual growth rate (C...
November 2025
225 pages
Middle East & Africa Bacterial Vaginosis Drug Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription Drugs and Over-the-Counter Drugs), Route of Administration (Oral, Topical, and Vaginal), Dosage Form (Creams, Gels, Pills, Solutions/Washes, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Middle East and Africa Bacterial Vaginosis (BV) Drug Market is projected to grow significantly, reaching an estimated US$ 150.5 million by 2031, up from US$ 89.7 million in 2024. This growth repre...
November 2025
156 pages
Middle East & Africa Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Middle East & Africa (MEA) Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 64.4 billion by 2031, up from US$ 41.7 billion in 2024. This growth represents a...
November 2025
218 pages
North America Bacterial Vaginosis Drug Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription Drugs and Over-the-Counter Drugs), Route of Administration (Oral, Topical, and Vaginal), Dosage Form (Creams, Gels, Pills, Solutions/Washes, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The North America Bacterial Vaginosis Drug Market is projected to grow significantly, reaching an estimated US$ 1,688.3 million by 2031, up from US$ 942.6 million in 2024. This growth represents a com...
November 2025
143 pages
North America Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The North America Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 1,157.0 billion by 2031, up from US$ 707.7 billion in 2024, reflecting a compound annual growt...
November 2025
210 pages
South & Central America Bacterial Vaginosis Drug Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription Drugs and Over-the-Counter Drugs), Route of Administration (Oral, Topical, and Vaginal), Dosage Form (Creams, Gels, Pills, Solutions/Washes, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The South and Central America Bacterial Vaginosis (BV) Drug Market is projected to grow significantly, reaching an estimated US$ 236.6 million by 2031, up from US$ 139.1 million in 2024. This growth r...
November 2025
149 pages
South & Central America Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route Of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The South & Central America Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 82.5 billion by 2031, up from US$ 52.5 billion in 2024. This growth represents a com...
November 2025
212 pages
